Shingles Vaccine Drastically Cuts Risk of Serious Cardiac Events

WASHINGTON (Mar 17, 2026)

People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events a year later compared with those who did not get the vaccine, according to a study being presented at the American College of Cardiology’s Annual Scientific Session (ACC.26)…

https://www.acc.org/about-acc/press-releases/2026/03/16/19/33/shingles-vaccine-drastically-cuts-risk-of-serious-cardiac-events

4 Likes

Without a randomized trial I think there’s residual confounding. Doesn’t mean you shouldn’t get the vaccine. All of the vaccine association studies feel like this to me. But they’re still good.

2 Likes

Completely agree. It’s exciting results but correlation vs causation is a possibility factor here.

2 Likes

I asked Gemini “Since this was an observational study what are the limitations in interpreting the results.”

Here is the answer:

While the results of the study are striking, the fact that it was observational (rather than a randomized controlled trial) means there are several inherent limitations in how the findings should be interpreted.

Here are the primary limitations associated with this type of research:

1. Correlation vs. Causation

The most significant limitation of any observational study is that it can identify a link (correlation) between two things, but it cannot definitively prove that one caused the other. In this case, while the shingles vaccine is associated with fewer heart attacks, the study cannot rule out other underlying reasons why vaccinated people had better heart health.

2. Healthy User Bias (Confounding)

This is a major factor in vaccine research. People who proactively seek out vaccines like Shingrix often differ from those who do not in several ways that affect heart health:

Health Literacy: They may be more likely to follow other medical advice, such as taking statins or blood pressure medication correctly.

Lifestyle Factors: They may be more likely to exercise, eat a heart-healthy diet, or avoid smoking.

Healthcare Access: People getting vaccinated clearly have access to healthcare and insurance, which are themselves strong predictors of better cardiac outcomes.

Even though the researchers “controlled” for some of these factors, it is almost impossible to account for every subtle lifestyle difference between the two groups.

3. Dependency on Electronic Health Records (EHR)

The study used TriNetX, a massive database of electronic health records. This introduces potential issues with data quality:

Coding Errors: Doctors or administrative staff may not always code every diagnosis or procedure perfectly.

Missing Data: If a patient received their vaccine at a local pharmacy or a different health system, it might not appear in the database, potentially misclassifying a “vaccinated” person as “unvaccinated.”

Detection Bias: People who see their doctor often (and thus get vaccinated) are also more likely to have their heart issues detected and treated early.

4. Limited Timeframe

The study focused on outcomes within one year of vaccination. While the results during that year were dramatic, observational data often struggles to show:

Long-term Efficacy: Does the heart protection wear off after two, five, or ten years?

Delayed Effects: Are there any long-term risks that weren’t captured in a 12-month window?

5. Selection Bias

The study specifically looked at people with pre-existing atherosclerotic heart disease. While this helps us understand high-risk patients, the results might not be exactly the same for a younger, healthier population or for people with different types of heart issues (like valvular disease).

Why the study is still important

Despite these limitations, observational studies like this are crucial because:

Scale: It is nearly impossible to run a randomized trial with 246,000 people over many years.

Real-World Evidence: It shows how the vaccine performs in the “real world” across diverse medical systems, rather than in the highly controlled environment of a clinical trial.

Hypothesis Generation: These results provide a strong “signal” that justifies further, more controlled clinical research into how vaccines impact systemic inflammation and heart health.

Considering how nasty shingles is, avoiding it is probably worth getting the vaccine on it’s own!

1 Like

It’s also a free vaccine for many people—those with Medicare Part D, or most people on private insurance.

I originally tried to get vaccinated, but the doctor told me there’s no way around the age limit. They said the shingles vaccine is useless for young people and that if I really wanted it, I’d have to go somewhere like Hong Kong.

Over here I know a lot of people under the age limit getting Shingles. I don’t know why there is a firm age limit. It boggles the mind.

1 Like